8-K: Centene Corporation Withdraws 2025 Financial Guidance Amid Significant Marketplace Risk Adjustment and Medicaid Cost Challenges

Centene Corporation has withdrawn its 2025 GAAP and adjusted diluted earnings per share guidance, citing a preliminary estimated $1.8 billion reduction in Marketplace risk adjustment revenue and a $2.75 adjusted diluted EPS impact, alongside rising Medicaid medical costs.

Summary

• Centene Corporation has officially withdrawn its previously issued 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including all underlying guidance elements.
• The withdrawal is primarily driven by new 2025 industry Health Insurance Marketplace (Marketplace) data from Wakely, an independent actuarial firm.
• Preliminary analysis of data from 22 of Centene's 29 Marketplace states, representing approximately 72% of Marketplace membership, indicates lower than expected overall market growth and significantly higher aggregate market morbidity.
• This preliminary analysis suggests a reduction of approximately $1.8 billion in the full year net risk adjustment revenue transfer, corresponding to an adjusted diluted EPS impact of approximately $2.75.
• This estimate is based on 2025 paid claims through April 30 for the 22 states, as well as Centene's membership and morbidity trend estimates.
• An additional reduction to net risk adjustment revenue transfer and corresponding EPS impact is anticipated for the remaining seven Marketplace states, for which data is not yet available.
• Centene's Medicaid business has experienced a step-up in medical cost trend, particularly in behavioral health, home health, and high-cost drugs, with New York and Florida being more pronounced.
• The second quarter 2025 Medicaid Health Benefits Ratio (HBR) is expected to be higher than the first quarter 2025 Medicaid HBR.

Sentiment

Score: 2

Explanation: The withdrawal of full-year guidance, coupled with a significant preliminary estimated negative EPS impact of $2.75 and rising Medicaid costs, indicates a substantially negative financial outlook despite some positive performance in other segments. The need for corrective pricing actions for 2026 also suggests ongoing challenges.

Positives

• The Company's Medicare Advantage and Medicare Prescription Drug Plan businesses are performing better than expected in the second quarter 2025.
• Centene continues to achieve strong selling, general and administrative (SG&A) expense leverage on its consolidated premium and service revenue growth.
• Final 2024 risk adjustment results released by the Centers for Medicare and Medicaid Services (CMS) were in line with expectations, including offsetting increases in Minimum Medical Loss Ratio (MLR) payable and Risk Adjustment Data Validation (RADV) accrual.
• Centene has commenced refiling 2026 Marketplace rates to account for a higher projected baseline of Marketplace morbidity.
• Corrective pricing actions for 2026 are expected to be implemented in states representing a substantial majority of Marketplace membership.

Negatives

• Withdrawal of all previously issued 2025 GAAP and adjusted diluted earnings per share guidance.
• Preliminary estimated reduction of approximately $1.8 billion in full year net risk adjustment revenue transfer for the Marketplace segment.
• Corresponding preliminary estimated adjusted diluted EPS impact of approximately $2.75 due to Marketplace risk adjustment issues.
• Lower than expected overall market growth and significantly higher aggregate market morbidity in the Health Insurance Marketplace.
• Anticipated additional negative impact on net risk adjustment revenue transfer and EPS from the remaining seven Marketplace states.
• Step-up in medical cost trend in the Medicaid business, particularly in behavioral health, home health, and high-cost drugs.
• Medicaid cost trends were more pronounced in specific geographies like New York and Florida, including carve-ins of related services without sufficient rate or risk adjustment.
• The second quarter 2025 Medicaid Health Benefits Ratio (HBR) is expected to be higher than the first quarter 2025 Medicaid HBR.

Risks

• Uncertainty regarding the full impact of Marketplace morbidity trends on the remaining seven Marketplace states' risk adjustment revenue.
• Continued step-up in medical cost trends within the Medicaid business, particularly in specific geographies and service areas.
• Potential for new information from CMS regarding another carrier's late 2024 submission to impact 2024 risk adjustment results.
• Ability to effectively design and price products that are competitive and actuarially sound, including impacts from Medicaid redeterminations.
• Ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates.
• Rate cuts, insufficient rate changes, or other payment reductions or delays by governmental payors.
• Changes in federal or state laws or regulations, including those related to the Patient Protection and Affordable Care Act (ACA) and enhanced advance premium tax credits.
• Unanticipated increased healthcare costs due to changes in consumer behavior, inflation, and tariffs.
• Ability to maintain or achieve improvement in CMS Star ratings and other quality scores, which could impact revenue and future growth.
• Competition for providers, broker distribution networks, and contract reprocurements.
• Ability to adequately anticipate demand and timely provide operational resources to meet service level requirements.
• Disruption, unexpected costs, or similar risks from business transactions, including acquisitions and divestitures.
• Changes in senior management or inability to attract and retain skilled personnel.
• Membership and revenue declines or unexpected trends.
• Changes in healthcare practices, new technologies, and advances in medicine.
• Ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws.
• Changes in macroeconomic conditions, including inflation, interest rates, and financial market volatility.
• Negative public perception of the Company and the managed care industry.
• Uncertainty concerning government shutdowns, debt ceilings, or funding.
• Difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings, or matters.
• Cyber-attacks or other data security incidents or failure to comply with privacy, data, or security laws.

Future Outlook

Centene Corporation has commenced the process of refiling 2026 Marketplace rates to reflect a higher projected baseline of Marketplace morbidity. The Company expects to implement corrective pricing actions for 2026 in states representing a substantial majority of its Marketplace membership. Centene plans to report its second quarter 2025 results and provide additional insights on July 25, 2025.

Management Comments

• The overall market growth in the 22 states is lower than expected and the implied aggregate market morbidity in those states is significantly higher than, and materially inconsistent with, the Company's assumptions for risk adjustment revenue transfer used in the preparation of its previous 2025 consolidated guidance.
• The Company currently expects to be able to take corrective pricing actions for 2026 in states representing a substantial majority of its Marketplace membership.
• The Company's Medicaid business has experienced a step-up in medical cost trend in the same areas previously identified by the Company: behavioral health, home health and high-cost drugs.
• The Company's Medicare Advantage and Medicare Prescription Drug Plan businesses are performing better than expected in the second quarter 2025.
• The Company also continues to drive strong selling, general and administrative expense leverage on its consolidated premium and service revenue growth.

Industry Context

This announcement highlights significant challenges within the U.S. health insurance industry, particularly concerning the Health Insurance Marketplace and Medicaid segments. The issues with risk adjustment revenue transfers and rising medical costs, especially in specific geographies and service lines like behavioral health and high-cost drugs, reflect broader pressures on managed care organizations operating in government-sponsored programs. The need for corrective pricing actions for 2026 suggests a recalibration of market assumptions across the industry, potentially impacting other carriers with significant Marketplace exposure.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results for direct comparison.
• It references data from Wakely, an independent actuarial firm, which collects data from "most Marketplace insurance carriers," implying a market-wide context for the observed trends.
• The Centers for Medicare and Medicaid Services (CMS) is mentioned as the source for 2024 risk adjustment results, which were in line with Centene's expectations, suggesting that the 2024 results were consistent with broader industry outcomes for that period.

Stakeholder Impact

• Shareholders: Highly negative impact expected due to the withdrawal of financial guidance and significant preliminary estimated reduction in EPS, likely leading to a decrease in share price.
• Customers (Marketplace members): Potential impact from future corrective pricing actions for the 2026 plan year, which may result in higher premiums.
• Government Payors (CMS, State Medicaid agencies): Ongoing discussions and adjustments related to risk adjustment and Medicaid rates, potentially leading to further scrutiny or negotiations.

Next Steps

• Centene is in the process of closing the second quarter and analyzing data, including in Marketplace and Medicaid.
• Report second quarter 2025 results and provide additional insights on July 25, 2025.
• Commenced the process of refiling 2026 Marketplace rates to reflect a higher projected baseline of Marketplace morbidity.
• Expects to take corrective pricing actions for 2026 in states representing a substantial majority of its Marketplace membership.

Key Dates

Recommendation

Keywords

Healthcare, Managed Care, Health Insurance Marketplace, Medicaid, Medicare Advantage, EPS Guidance, Risk Adjustment, Medical Loss Ratio, Healthcare Costs, Financial Guidance, Centene Corporation, CNC, SEC Filing, 8-K, Earnings Per Share, Actuarial, Morbidity, Health Benefits Ratio